VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2020 | Highlights in Lymphoma at ASH 2020

Loretta Nastoupil, MD, University of Texas MD Anderson Center, Houston, TX, shares her enthusiasm on recent advances in the lymphoma field presented at ASH 2020. Multiple clinical trials are underway assessing bispecific antibodies in the treatment of large B-cell lymphoma (LBCL) and follicular lymphoma (FL), where high efficacy rates and tolerable safety profiles are being reported. She goes on to discuss the emerging data on CAR T-cell therapy, specifically the ZUMA-5 and ELARA studies. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter